ZEVASKYN
STN: 125807
Proper Name: prademagene zamikeracel
Tradename: ZEVASKYN
Manufacturer: Abeona Therapeutics, Inc.
Indications:
- ZEVASKYN is an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB).